نتایج جستجو برای: familial breast cancer

تعداد نتایج: 1032090  

2016
Jingjing Liu Wendy J. C. Prager–van der Smissen Marjanka K. Schmidt J. Margriet Collée Sten Cornelissen Roy Lamping Anja Nieuwlaat John A. Foekens Maartje J. Hooning Senno Verhoef Ans M. W. van den Ouweland Frans B. L. Hogervorst John W. M. Martens Antoinette Hollestelle

The HOXB13 p.G84E mutation has been firmly established as a prostate cancer susceptibility allele. Although HOXB13 also plays a role in breast tumor progression, the association of HOXB13 p.G84E with breast cancer risk is less evident. Therefore, we comprehensively interrogated the entire HOXB13 coding sequence for mutations in 1,250 non-BRCA1/2 familial breast cancer cases and 800 controls. We...

Journal: :The breast journal 2006
Julie M Turner-Cobb Lindsey E Bloor Alice S Whittemore Dee West David Spiegel

Using a cross-sectional, exploratory design, this pilot study analyzed the relationships between familial history of breast cancer and psychological distress in order to evaluate who is more distressed and to assess the possible need for intervention. Coping style, social support, and family relations were investigated as potential moderators of these relationships. Participants were 45 women w...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2006
Mary B Daly Robert Pilarski Jennifer E Axilbund Michael Berry Saundra S Buys Beth Crawford Meagan Farmer Susan Friedman Judy E Garber Seema Khan Catherine Klein Wendy Kohlmann Allison Kurian Jennifer K Litton Lisa Madlensky P Kelly Marcom Sofia D Merajver Kenneth Offit Tuya Pal Huma Rana Gwen Reiser Mark E Robson Kristen Mahoney Shannon Elizabeth Swisher Nicoleta C Voian Jeffrey N Weitzel Alison Whelan Myra J Wick Georgia L Wiesner Mary Dwyer Rashmi Kumar Susan Darlow

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer and are intended to assist with clinical and shared decision-making. These NCCN Guidelines I...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2002
Jaya M Satagopan Jeff Boyd Noah D Kauff Mark Robson Lauren Scheuer Steven Narod Kenneth Offit

PURPOSE Several studies to date have reported ovarian cancer risk due to inherited BRCA1 and BRCA2 mutations using familial data or population-based series of probands. Familial aggregation associated with both of these methods may result in a substantial ascertainment bias. To address this, we have used a case-control design that does not involve familial aggregation to estimate the lifetime p...

2015
Masoud Sadeghi Mehrdad Payandeh Reza Khodarahmi Edris Sadeghi

Mutations of germ-cell line TP53 gene are mainly reported in Li–Fraumeni syndrome(LFS). LFS-associated breast cancers are both hormone receptor and human epidermal growth factor receptor 2 positive. The purpose of this study is presentation of one case of LFS, associated with familial hyperlipidemias. A 52-year-old woman referred to clinic of oncology with a pain in the left breast. Her patholo...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Mira Heinonen Rainer Fagerholm Kirsimari Aaltonen Outi Kilpivaara Kristiina Aittomäki Carl Blomqvist Päivi Heikkilä Caj Haglund Heli Nevanlinna Ari Ristimäki

PURPOSE HuR is an mRNA-binding protein that enhances the stability of certain transcripts and can regulate their translation. Elevated cytoplasmic expression of HuR protein has been linked to carcinogenesis and is associated with reduced survival in breast, ovarian, and gastric adenocarcinomas. EXPERIMENTAL DESIGN Here, we have explored the relevance of HuR in familial breast cancer. Tumor sa...

Journal: :Dermatology 2001
C Hildenbrand W H Burgdorf S Lautenschlager

Cowden syndrome is a rare autosomal dominant familial cancer syndrome with a high risk of breast cancer. The most important clinical features include carcinomas of the breast and thyroid, and hamartomatous polyps of the gastrointestinal tract. There are characteristic mucocutaneous features which allow early recognition of the disease and are generally present before internal malignancies devel...

2017
Jolien S. de Groot Paul J. van Diest Patrick W.B. Derksen

Journal: :Science 2009
Siân Jones Ralph H Hruban Mihoko Kamiyama Michael Borges Xiaosong Zhang D Williams Parsons Jimmy Cheng-Ho Lin Emily Palmisano Kieran Brune Elizabeth M Jaffee Christine A Iacobuzio-Donahue Anirban Maitra Giovanni Parmigiani Scott E Kern Victor E Velculescu Kenneth W Kinzler Bert Vogelstein James R Eshleman Michael Goggins Alison P Klein

Through complete sequencing of the protein-coding genes in a patient with familial pancreatic cancer, we identified a germline, truncating mutation in PALB2 that appeared responsible for this patient's predisposition to the disease. Analysis of 96 additional patients with familial pancreatic cancer revealed three distinct protein-truncating mutations, thereby validating the role of PALB2 as a s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید